Please note: The information displayed on this page might be outdated.
Xilio Therapeutics: Xilio Therapeutics is a biotechnology company advancing next-generation cancer immunotherapies designed to improve patient outcomes by unleashing the power of the immune system selectively at the site of the tumor. The company’s tumor-selective immunotherapies are based on its proprietary technology, which maximizes the potency of proven immuno-oncology therapies and restricts their activity to the tumor to minimize peripheral side effects. The broad applicability of these therapies across cancer types means that all patients could benefit from these potentially curative medicines.

Xilio was founded in 2016 and is headquartered in Waltham, Mass.
Based in...
US - New England
Waltham, MA
United States

Company Participants at Fall Private Company Showcase 2020

  • Rene Russo, CEO

Upcoming Company Event Participation

Fall Private Company Showcase 2020

VIRTUAL, October 15, 2020